20 January 2014
In 2013, Russia’s nanotech companies generated about $1.5bn worth of products, according to preliminary results voiced by Anatoly Chubais. The Rusnano president made this estimate, reported by Russian business daily RBC, at a most recent meeting with Prime Minister Dmitry Medvedev of Russia.
“We have our main KPI to focus on, and this is output volumes. In 2011, we only had about $30m; the next year it was $380m already,” Mr. Chubais said, adding that official data would soon come from Rosstat [Russia’s federal statistics agency – Editor’s note]. “We can see even now from our tentative estimates that we made it with $1.5bn last year,” the head of Russia’s nanotech giant claimed.
According to Mr. Chubais, Rusnano has facilitated the launch of 53 new nanotech-focused factories in Russia since its start in 2007. The key guideline for Rusnano to invest is finding a private co-investor willing to kick in. “To each ruble we invest, our co-investors add between 1.5 and 2 rubles,” the Rusnano president said.
Prime Minister Medvedev emphasized the importance of “sticking to this key guideline in the future.”
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024